🔍

GEMAROMA - Gem Aromatics

📊 NSE: GEMAROMA 🏢 Specialty Chemicals 📅 Last Updated: 11/13/2025 15:25

📢 Recent Corporate Announcements

Gem Aromatics Promoter & CFO Kaksha Vipul Parekh Acquires 60,000 Shares via Market Purchase

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 13 Mar 2026, 06:27 PM

Kaksha Vipul Parekh, a Promoter and the Whole-Time Director & CFO of Gem Aromatics, has increased their stake in the company through open market transactions. On March 13, 2026, the promoter purchased a total of 60,000 equity shares across the BSE and NSE platforms. This acquisition, valued at approximately ₹1.05 crore, raised the promoter's individual holding from 8.66% to 8.77%. Insider buying of this nature is generally interpreted as a sign of management's confidence in the company's intrinsic value and future growth.

Promoter Kaksha Vipul Parekh purchased 60,000 equity shares on March 13, 2026.
The total transaction value was approximately ₹1.05 crore excluding taxes and brokerage.
The promoter's individual shareholding increased from 8.66% (4,523,219 shares) to 8.77% (4,583,219 shares).
The acquisition was conducted through open market purchases on both the BSE and NSE.

💡 Investors should take note of this insider buying as a positive signal regarding the company's outlook. While the stake increase is relatively small (0.11%), the CFO's personal investment suggests alignment with shareholder interests.

Promoter & CFO Kaksha Vipul Parekh Acquires 60,000 Shares of Gem Aromatics for ₹1.06 Cr

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 13 Mar 2026, 06:23 PM

Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, purchased 60,000 equity shares via open market transactions on March 13, 2026. The total acquisition cost was approximately ₹1.06 crore, with 50,000 shares bought on BSE and 10,000 on NSE. This purchase increased the promoter's individual stake from 8.66% to 8.77%. Such insider activity often signals management's belief that the current stock price is attractive or that future prospects are strong.

Purchase of 60,000 shares by Whole-Time Director & CFO Kaksha Vipul Parekh
Total investment value of approximately ₹1.06 crore through open market purchases
Promoter's individual stake increased from 8.66% to 8.77% following the transaction
Purchases were conducted on both BSE (50,000 shares) and NSE (10,000 shares) on March 13, 2026

💡 This insider purchase is a positive indicator of management's long-term confidence in the business. Investors may consider this a supportive factor for the stock's valuation, though fundamental analysis of the company's earnings remains necessary.

Gem Aromatics Promoter & CFO Kaksha Vipul Parekh Acquires 60,000 Shares for ₹1.06 Crore

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 12 Mar 2026, 06:38 PM

Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, has increased their stake in the company through an open market purchase on March 12, 2026. The transaction involved the acquisition of 60,000 equity shares for a total consideration of approximately ₹1.06 crore. This purchase raises the promoter's individual holding from 5.46% to 5.56%. Such insider buying by a key management person is typically interpreted as a sign of confidence in the company's long-term value.

Acquisition of 60,000 equity shares via open market on the BSE
Total transaction value amounts to ₹1,05,99,000
Promoter's stake increased from 5.46% to 5.56% following the transaction
Transaction executed by Kaksha Vipul Parekh, who serves as Whole-Time Director and CFO

💡 Investors should take this as a positive signal of management's confidence in the company's valuation. While insider buying is encouraging, it should be weighed alongside the company's quarterly financial performance.

Gem Aromatics Promoter & CFO Acquires 60,000 Shares Worth ₹1.06 Crore

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 12 Mar 2026, 06:33 PM

Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, purchased 60,000 shares through an open market transaction on March 12, 2026. The acquisition, valued at approximately ₹1.06 crore, increased her personal stake from 49.46% to 50.12%. Such insider buying by a key financial officer often indicates strong internal confidence in the company's valuation and future performance. This transaction is significant as it crosses the 50% individual ownership threshold for the promoter.

Purchase of 60,000 equity shares by CFO Kaksha Vipul Parekh via open market
Total transaction value estimated at ₹1,05,99,000
Individual promoter stake increased from 49.46% to 50.12%
Transaction was executed on the BSE on March 12, 2026

💡 Investors should view this insider buying by the CFO as a positive signal of management's commitment and confidence in the company's long-term prospects.

Gem Aromatics Promoter & CFO Acquires 50,000 Shares Worth ₹93.12 Lakhs

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 11 Mar 2026, 06:01 PM

Kaksha Vipul Parekh, the Promoter and CFO of Gem Aromatics Limited, purchased 50,000 equity shares through an open market transaction on March 11, 2026. The acquisition, valued at approximately ₹93.12 lakhs, raised the promoter's stake from 64.54% to 65.27%. This move reflects strong internal confidence in the company's current valuation and long-term business outlook. Insider buying at this scale is often interpreted by the market as a bullish indicator.

Acquisition of 50,000 equity shares by Promoter and CFO Kaksha Vipul Parekh.
Total transaction value reported at ₹93,12,500 through an on-market purchase.
Individual promoter holding increased from 64.54% to 65.27% post-transaction.
The transaction was executed on March 11, 2026, and disclosed under SEBI PIT regulations.

💡 Investors should view this insider purchase as a positive signal regarding the company's intrinsic value. It may be worth monitoring the stock for further accumulation by other members of the promoter group.

Gem Aromatics Promoter Kaksha Vipul Parekh Acquires 50,000 Shares for ₹93.12 Lakhs

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 11 Mar 2026, 05:50 PM

Kaksha Vipul Parekh, the Whole-Time Director and CFO of Gem Aromatics, has purchased 50,000 equity shares of the company through an open market transaction on March 11, 2026. The total value of the acquisition is approximately ₹93.12 lakhs. This purchase has increased the promoter's individual stake from 8.45% to 8.546%. Such insider buying typically indicates management's confidence in the company's future prospects and intrinsic value.

Promoter and CFO Kaksha Vipul Parekh purchased 50,000 shares via the open market on NSE
The total transaction value is approximately ₹93.12 lakhs
Individual shareholding of the promoter increased from 8.45% to 8.546%
The acquisition was completed on March 11, 2026, as per SEBI PIT regulations

💡 Investors should consider this insider buying as a positive signal regarding the company's valuation and outlook. It is advisable to monitor further insider activity and quarterly performance to confirm the growth trajectory.

Gem Aromatics to Participate in Arihant Capital Investor Conference on March 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 07 Mar 2026, 10:34 AM

Gem Aromatics Limited has scheduled a virtual investor meeting on March 11, 2026, as part of the Bharat Connect Conference Rising Stars hosted by Arihant Capital. The meeting is set to take place from 12:00 PM to 1:00 PM to engage with analysts and institutional investors. Management will utilize the existing Q3 and 9MFY26 investor presentation, which is already available in the public domain. Such interactions are standard procedures for listed companies to improve transparency and investor relations.

Virtual investor meeting scheduled for Wednesday, March 11, 2026, at 12:00 PM.
Participation in the 'Bharat Connect Conference Rising Stars' organized by Arihant Capital.
Discussion will focus on the previously disclosed Q3 and 9MFY26 financial performance.
The interaction aims to provide institutional investors and analysts with deeper insights into company operations.

💡 Investors should review the existing Q3 and 9MFY26 presentation and watch for any post-conference transcripts that may offer additional management commentary on future growth.

Promoter Vipul Nathalal Parekh Acquires 0.57% Stake in Gem Aromatics via Open Market

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 04 Mar 2026, 05:15 PM

Mr. Vipul Nathalal Parekh, a promoter of Gem Aromatics Limited, has increased his stake by acquiring 3,00,000 equity shares through the open market. This transaction, completed on March 04, 2026, represents a 0.57% increase in his total holding. Consequently, his individual stake in the company has risen from 17.64% to 18.21%. Promoter buying from the open market is typically interpreted as a strong signal of confidence in the company's valuation and long-term growth prospects.

Acquisition of 3,00,000 equity shares (0.57% stake) by promoter Vipul Nathalal Parekh.
Transaction executed via open market on March 04, 2026.
Promoter's total shareholding increased from 92,16,748 shares (17.64%) to 95,16,748 shares (18.21%).
Total paid-up equity capital of the company remains at 5,22,37,138 shares with a face value of Rs. 2 each.

💡 This insider purchase suggests the promoter believes the current market price is attractive. Investors should view this as a positive indicator of internal confidence while continuing to monitor the company's quarterly performance.

Gem Aromatics Promoter Vipul Nathalal Parekh Acquires 3 Lakh Shares for ₹6.19 Crores

🟢 POSITIVE ⭐ 7/10

REGULATORY 📅 04 Mar 2026, 05:07 PM

Vipul Nathalal Parekh, a Promoter and Whole-Time Director of Gem Aromatics Limited, has acquired 3,00,000 equity shares of the company through an open market transaction on March 04, 2026. The total value of the acquisition is approximately ₹6.19 Crores, reflecting a significant personal investment. This purchase has increased his individual stake from 17.64% to 18.21%. Such substantial promoter buying is typically interpreted as a strong signal of confidence in the company's long-term value and future prospects.

Promoter Vipul Nathalal Parekh purchased 3,00,000 equity shares via the open market on March 04, 2026.
The total transaction value is approximately ₹6.187 crore, excluding taxes and brokerage.
The promoter's individual shareholding increased from 17.64% (92,16,748 shares) to 18.21% (95,16,748 shares).
The acquisition was executed on the National Stock Exchange (NSE).
This disclosure was made under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 Investors should view this increase in promoter stake as a positive indicator of management's confidence in the company's intrinsic value. It may be worth monitoring the stock for further insider activity or upcoming growth catalysts.

Gem Aromatics Starts New Production at Dahej & Secures $1M Export Orders

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 26 Feb 2026, 08:55 PM

Gem Aromatics has commenced commercial production of cooling agents (GEM Cool 5) and Safranal at its Dahej facility through its subsidiary, Krystal Ingredients. The company also secured new export orders totaling USD 1 million from the USA and Europe, signaling a revival in international demand due to easing tariff headwinds. This expansion is part of a larger growth strategy where the company is adding 9,229 MTPA capacity to its existing 6,946 MTPA. Management expects the manufacturing of Catalyst for MEHQ to be completed by Q4FY26, further diversifying the product portfolio.

Commenced commercial production of GEM Cool 5 and Safranal at the Dahej greenfield facility
Secured new export orders aggregating to USD 1 million from USA and European markets
Total installed capacity stands at 6,946 MTPA with an additional 9,229 MTPA under expansion
Manufacturing of Catalyst for MEHQ is on track for completion by Q4FY26
Revival in export demand attributed to proposed EU FTA and US tariff reductions

💡 Investors should monitor the revenue ramp-up from the Dahej facility and the successful commissioning of the remaining 9,229 MTPA capacity. The stock offers growth potential as the company transitions from pilot runs to full-scale commercial operations in high-value specialty chemicals.

Gem Aromatics Bags $1M Export Orders and Starts New Product Production at Dahej Facility

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 26 Feb 2026, 08:32 PM

Gem Aromatics has secured new export orders totaling USD 1 million from the USA and Europe, signaling a revival in international demand following tariff reductions and trade agreements. The company has also commenced commercial production of new products, including cooling agents and Citral derivatives, at its Dahej greenfield facility via its subsidiary, Krystal Ingredients. This expansion is part of a larger strategy to utilize an additional 9,229 MTPA capacity currently under pilot run. Furthermore, the company expects to complete the manufacturing setup for MEHQ catalysts by Q4FY26.

Received new export orders worth USD 1 million from customers in the USA and Europe
Commenced commercial production of GEM Cool 5 (Cooling Agents) and Safranal at Dahej facility
Company is scaling up with 9,229 MTPA additional capacity currently under pilot run
Manufacturing of Catalyst for MEHQ is on track for completion by Q4FY26
Export revival driven by proposed EU FTA and easing of US tariff headwinds

💡 Investors should track the successful transition of the 9,229 MTPA pilot capacity into full commercial operations as it will significantly boost revenue. The recovery in high-margin export markets is a positive indicator for bottom-line growth in the coming quarters.

Gem Aromatics Schedules Plant Visit for 20+ Institutional Investors at Dahej Facility

🟢 POSITIVE ⭐ 6/10

ROUTINE 📅 12 Feb 2026, 12:16 PM

Gem Aromatics Limited has announced a plant visit for over 20 institutional investors and analysts on February 24, 2026. The visit will take place at the company's Unit 3 facility in Dahej, Gujarat, from 11:30 AM to 3:30 PM. Notable participants include HDFC Securities, Lucky Investment Managers, and Prabhudas Liladhar. The company intends to use its Q3 & 9MFY26 investor presentation for the interaction, highlighting its operational setup to the investment community.

Plant visit scheduled for February 24, 2026, at the Dahej, Gujarat manufacturing unit.
Over 20 major institutional investors and fund houses confirmed for the site visit.
Participating firms include HDFC Securities, SageOne Investments, and Nirmal Bang Securities.
Discussions will be based on the existing Q3 and 9MFY26 investor presentation.

💡 Investors should watch for potential research coverage or updates from the participating institutional firms following the site visit. The significant interest from multiple fund houses suggests a positive outlook on the company's manufacturing capabilities.

Gem Aromatics Schedules Plant Visit for New Berry Advisors on February 17, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 12 Feb 2026, 12:01 PM

Gem Aromatics Limited has announced a scheduled investor meeting and plant visit for New Berry Advisors Pvt. Ltd on February 17, 2026. The visit is set to take place at the company's Unit 3 facility in Dahej, Gujarat, from 11:30 AM to 3:30 PM. The company will use its existing Q3 & 9MFY26 investor presentation, which is already available in the public domain. This engagement indicates ongoing institutional interest and operational transparency regarding the company's manufacturing capabilities.

Investor meet and plant visit scheduled for February 17, 2026, with New Berry Advisors Pvt. Ltd.
The visit will focus on the Unit 3 facility located in Dahej, Gujarat.
The interaction is scheduled for a four-hour window between 11:30 AM and 3:30 PM.
Discussions will be based on the previously disclosed Q3 & 9MFY26 investor presentation.

💡 Investors should monitor for any subsequent research reports or updates from the visiting institution. No immediate trading action is required based on this routine disclosure.

Gem Aromatics Appoints Shrenik Vora as Director with 99.98% Shareholder Approval

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 09 Feb 2026, 06:33 PM

Gem Aromatics Limited has announced the successful passage of an ordinary resolution via postal ballot for the appointment of Mr. Shrenik Kishorbhai Vora as a Non-Executive, Non-Independent Director. The resolution received overwhelming support with 99.98% of the total valid votes cast in favour, representing 3,03,54,371 shares. While promoters and institutional investors voted 100% in favour, the public non-institutional segment showed some dissent with 33.78% of their polled votes against the resolution. The appointment is deemed effective from February 07, 2026.

Ordinary resolution for the appointment of Mr. Shrenik Kishorbhai Vora as Director passed with 99.98% majority.
A total of 3,03,61,714 valid votes were polled, with 3,03,54,371 in favour and only 7,343 against.
Promoter group and Public Institutions showed 100% consensus, polling 2,87,64,369 and 15,75,610 votes in favour respectively.
Public non-institutional shareholders cast 21,735 votes, of which 14,392 (66.22%) were in favour and 7,343 (33.78%) were against.

💡 This is a routine management update with strong shareholder backing. Investors should monitor if this board change leads to any shifts in corporate strategy or governance.

Gem Aromatics to Hold 1-on-1 Meets with Motilal Oswal, Ashmore & Others in Feb 2026

🟢 POSITIVE ⭐ 4/10

ROUTINE 📅 09 Feb 2026, 12:46 PM

Gem Aromatics Limited has scheduled a series of one-on-one in-person meetings with five institutional investors on February 13 and February 23, 2026. The list of participants includes prominent names such as Motilal Oswal Principal Fund, Ashmore Investments, and Farley Capital. These meetings will focus on the company's Q3 and 9MFY26 performance based on previously disclosed investor presentations. Such interactions often precede increased institutional participation or research coverage for the stock.

Four 1-on-1 meetings scheduled for February 13, 2026, starting from 10:30 AM.
Participating funds include New Mark Capital, Aionis Alpha, Ashmore Investments, and Motilal Oswal.
A fifth meeting with Farley Capital is set for February 23, 2026, at 4:00 PM.
The company will use the Q3 & 9MFY26 Investor Presentation published in January 2026 for discussions.

💡 Investors should view this as a sign of increasing institutional curiosity; monitor for any future changes in institutional shareholding patterns.

View All GEMAROMA Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue for Q2 FY26 was INR 89.5 Cr, a decline of 20.2% YoY from INR 112.2 Cr. H1 FY26 revenue stood at INR 177.2 Cr, down 13.5% YoY. The Mint portfolio, which accounted for 70% of FY25 revenue, saw significant volume contraction due to external headwinds, while Phenol derivatives and other natural/synthetic products remained healthy but lacked the scale to offset the Mint decline.

Geographic Revenue Split

The USA is a critical market, contributing 30% of total revenue in FY25. The company serves a global base of 269+ customers across 18 countries, including major flavor and fragrance houses and FMCG companies.

Profitability Margins

Gross Profit Margin for Q2 FY26 was 14.0%, a sharp decline of 805 bps YoY from 22.1%. PAT Margin for Q2 FY26 turned negative at -2.9% (INR 2.6 Cr loss) compared to 8.7% (INR 9.7 Cr profit) in Q2 FY25. H1 FY26 PAT margin was 3.1% (INR 5.4 Cr) versus 8.9% (INR 18.3 Cr) YoY.

EBITDA Margin

EBITDA Margin for Q2 FY26 crashed to 3.4% (INR 3.0 Cr) from 13.7% (INR 15.3 Cr) in Q2 FY25, a drop of 1,027 bps. H1 FY26 EBITDA margin was 10.1% (INR 17.9 Cr) compared to 14.4% (INR 29.6 Cr) YoY, impacted by high raw material costs and lower realizations in the Mint segment.

Capital Expenditure

The company completed capitalization of major assets at its subsidiary, Krystal Ingredients, in H1 FY26. The Net Block increased to INR 206.2 Cr as of September 30, 2025, from INR 43.4 Cr in March 2025. Capital Work-in-Progress (CWIP) stood at INR 25.1 Cr.

Credit Rating & Borrowing

The company utilized IPO proceeds to repay INR 140 Cr of debt, including INR 97.4 Cr of long-term debt for Krystal Ingredients and INR 42.6 Cr of working capital debt. This improved the Net Debt to Equity ratio from 0.8x to 0.3x. Finance costs for H1 FY26 were INR 7.0 Cr, up from INR 2.4 Cr YoY.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Natural Mint Oil, Synthetic Mint Oil, Clove Oil, and Phenol. Mint-based materials represent the largest cost component, historically supporting 70% of revenue.

Import Sources

Not explicitly disclosed, though the company operates facilities in Silvassa, Badaun (U.P.), and a new Greenfield project in Dahej (Gujarat).

Capacity Expansion

The company has established a new Greenfield multi-purpose plant at Dahej under Krystal Ingredients with a capacity of 10,829 units. This facility is designed to manufacture Phenol derivatives like MEHQ and other specialty aroma chemicals.

Raw Material Costs

Cost of Goods Sold (COGS) for H1 FY26 was INR 138.7 Cr, representing 78.3% of revenue. Profitability was pressured by high raw material costs in the Mint segment and inventory adjustments during Q2 FY26.

Manufacturing Efficiency

Depreciation increased to INR 4.9 Cr in H1 FY26 from INR 3.5 Cr YoY following the capitalization of the Dahej facility, impacting short-term net profitability.

Logistics & Distribution

Other expenses, including logistics and distribution, rose to INR 14.6 Cr in H1 FY26 from INR 11.6 Cr YoY.

📈 Strategic Growth

Expected Growth Rate

30%

Growth Strategy

The company aims to reach INR 1,050-1,100 Cr in revenue by FY28 with 16-18% EBITDA margins. This will be achieved by ramping up the Dahej multi-purpose facility, shifting the product mix from Mint (70% of revenue) toward higher-margin Phenol derivatives (MEHQ) and specialty Aroma chemicals, and expanding the global customer base beyond the current 269 clients.

Products & Services

Menthol, Mint derivatives, Clove Oil, Clove Oil derivatives, Phenol derivatives (MEHQ), and various Natural and Synthetic Aroma molecules.

Brand Portfolio

GEM Aromatics, Krystal Ingredients (Subsidiary).

New Products/Services

New value-added specialty Aroma products and Phenol derivatives (MEHQ) are being fast-tracked for launch to offset the 20.2% decline in Q2 revenue.

Market Expansion

Targeting new global customers for Menthol and Aroma chemicals as the Dahej production ramps up; currently serving 18 countries.

Strategic Alliances

doTERRA Enterprises, Sàrl is a strategic investor (shareholder) and a key customer, providing value-add to the business through long-standing partnership.

🌍 External Factors

Industry Trends

The industry is shifting toward natural and wellness-focused ingredients. GEM Aromatics is positioning itself as a specialty ingredient company by moving away from commodity mint into integrated chemistry and next-generation aroma molecules.

Competitive Landscape

Faces competition in the Phenol derivative business from existing Indian manufacturers, though the company's multi-purpose plant at Dahej is designed for margin-accretive specialty products.

Competitive Moat

Durable advantages include a 27-year operating history, integrated manufacturing capabilities, a diversified portfolio of 269+ global customers, and a strategic partnership with doTERRA. These are sustainable due to high entry barriers in specialty chemical manufacturing and long-term customer trust.

Macro Economic Sensitivity

Highly sensitive to international trade policies and domestic tax structures, as evidenced by the immediate impact of US tariffs and Indian GST changes.

Consumer Behavior

Shift toward natural ingredients and wellness products is driving demand for the company's natural aroma and essential oil portfolio.

Geopolitical Risks

Significant exposure to US-India trade relations; a 50% tariff on Indian imports imposed in August 2025 led to a 20.2% YoY revenue drop in Q2 FY26.

⚖️ Regulatory & Governance

Industry Regulations

Impacted by GST revisions effective September 2, 2025, which set Natural Mint Oil at 5% and Synthetic Mint Oil at 18% (previously a uniform 12%), disrupting domestic procurement and blending models.

Taxation Policy Impact

Effective tax rate for H1 FY26 was approximately 35% (INR 2.9 Cr tax on INR 8.3 Cr PBT).

⚠️ Risk Analysis

Key Uncertainties

Uncertainty regarding future US trade policies and the duration of the 50% tariff impact could continue to suppress 30% of the company's revenue stream.